1160.7000 0.30 (0.03%)
NSE May 07, 2025 15:31 PM
Volume: 1.4M
 

BOB Capital Markets Ltd.
North America sales missed our estimates and reported US$ 395mn in 3QFY25 vs US$ 445mn in 2QFY25 impacted by gRevlimid
Dr. Reddy's Laborato.. has an average target of 1347.12 from 10 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended